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Abstract

Refeeding syndrome is a syndrome of electrolyte abnormalities, which occurs in
patients who are fed orally, enterally, or parenterally (1). Patients at high risk of getting
refeeding syndrome include people with chronic malnutrition-underfeeding, classic
kwashiorkor, classic marasmus, anorexia nervosa, chronic alcoholism, morbid obesity
with massive weight loss, patients unfed in 7-10 days with evidence of stress and
depletion, patients with prolonged fasting, and patients with prolonged intravenous
hydration (1,2). Characteristics or complications of refeeding syndrome include
congestive heart failure, hypercapnia, hyperglycemia, rebound hypoglycemia,
hypophosphatemia, hypokalemia, hypomagnesemia, and hypocalcemia. Prevention is the
key in refeeding syndrome and it can be done by remembering "to start low and go
slow"(l ). Another important part of prevention is monitoring and supplementing
electrolytes if necessary before and during refeeding.
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Introduction
Refeeding syndrome is a syndrome of electrolyte abnormalities, which occurs in
malnourished patients who are refed orally, enterally, or parenterally (1). Some
characteristics or complications of refeeding syndrome include congestive heart failure,
hypercapnia, hyperglycemia, rebound hypoglycemia, hypophosphatemia, hypokalemia,
hypomagnesemia, and hypocalcemia (3). Prevention is very important and it is best
done by remembering ''to start low and go slow" (1).

People at higher risk for RS
Patients especially at risk for refeeding syndrome include people with chronic
malnutrition-underfeeding, classic kwashiorkor, classic marasmus, anorexia nervosa,
chronic alcoholism, morbid obesity with massive weight loss, patients unfed in 7-10 days
with evidence of stress and depletion, patients with prolonged fasting, and patients with
prolonged intravenous hydration (1,2). Refeeding syndrome occurring in starved patients
has been identified in medical literature since the 1940s (2). PEM is a "class of clinical
disorders resulting from varying combinations and degrees of protein and energy
deficiency, usually accompanied by additional physiologic and environmental insults and
stresses" (3). In developed countries PEM most often occurs secondary to trauma,
disease, psychologic problems, or medical treatment (3). Protein-energy malnutrition
(PEM) has been reported in greater than 40-50% of hospitalized patients (1,4).
Kwashiorkor and marasmus are the major forms ofPEM. Marasmus is more of a classic
starvation characterized by a deficiency of energy, which results in muscular wasting and
the absence of subcutaneous fat. (3). Kwashiorkor is characterized by extreme protein
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deficiency, which leads to hypoalbuminemia, pitting edema, and an enlarged fatty liver
(3). Albumin and prealbumin are good indicators of protein status and are often
measured in hospitalized patients. A normal serum albumin is 3.5-5.0 mg/di; a normal
serum prealbumin is 18-40 mg/dl ( 5). In one study a serum prealbumin less than 11
mg/di predicted the development of refeeding hypophosphatemia (6). Refeeding or
repletion of malnourished patients can cause unique metabolic alterations that can be
detrimental and fatal.

Functional and metabolic changes associated with chronic malnutrition
Chronic malnutrition is characterized by a loss of body weight which may occur
over a period of months or years due to a lack of, imbalance, or defective use of nutrients
(1,4). Other characteristics of chronic malnutrition include: 1) lean body mass and
adipose tissue are depleted; 2) basal metabolic rate (BMR) is decreased; 3) serum
proteins such as total protein, albumin, and transferrin are depleted; 4) insulin and thyroid
production and secretion are reduced to decrease BMR, conserve protein, and preserve
organ function; 5) amino acids are used as substrates for gluconeogenesis to provide
glucose for red blood cells and the central nervous system; 6) protein degradation is
decreased as starvation is prolonged; and 7) the brain mostly uses fatty acids and ketone
bodies for energy (1,4).
Mineral metabolism is altered in chronic malnutrition leading to a decrease in
body mineral stores (4).

Some alterations include an increased urinary excretion of

potassium, phosphorus, magnesium, and zinc, as lean tissue is degraded (4). However, as
starvation progresses and catabolism decreases, mineral excretion also decreases (4).
Calcium excretion remains elevated throughout starvation secondary to bone
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demineralization (4). Sodium, chloride, and water excretion are primarily dependent
upon intake (1).
During chronic malnutrition there are other changes in the body. Extracellular
fluid expands and intracellular fluid contracts (4). Also, the gastrointestinal (GI) tract,
respiratory tissue, the liver, and the heart may lose the ability to function properly (4).
The GI tract may lose absorptive surface due to villous atrophy and prolonged turnover of
crypt cells (1). Due to respiratory muscle wasting, there is a decrease in the vital capacity
and pulmonary ventilation in starvation (4). Atrophy of cardiac tissue also occurs during
starvation. This results in a decrease in contractility, cardiac output, and heart volume
(1,4).
Potential complications of refeeding
Many metabolic changes occur during the refeeding of a malnourished patient.
The body begins anabolism or rebuilding immediately when energy substrates are
reintroduced (3) During refeeding BMR increases and glucose becomes the main fuel
(4). Along with this, insulin and thyroid hormone secretion increase (4). Refeeding,
especially with carbohydrate, results in a decreased excretion of sodium and water and an
increase in total body water (1,7). Also, during refeeding starved body cells may take up
excessive glucose, potassium, phosphorus, and magnesium for ATP production (3). As
this shift to intracellular spaces occurs, serum levels of these minerals may fall rapidly
(4). These rapid metabolic changes can cause life-threatening complications. Some
potential complications or symptoms of refeeding syndrome are congestive heart failure,
hypercapnia, hyperglycemia, rebound hypoglycemia, hypophosphatemia, hypokalemia,
hypomagnesemia, and hypocalcemia (1,2,3,4,7).

5

The first potential complication ofrefeeding syndrome is congestive heart failure.
As previously mentioned, starvation can cause cardiac atrophy and dysfunction (1,2).
Refeeding with excessive calories, fluids, or both can stress the atrophied heart beyond
what it can handle (1,2). The stress on the atrophied organ increases oxygen
consumption and cardiac output, which may result in congestive heart failure (7).
Congestive heart failure is "the inability of the heart to pump sufficient blood throughout
the circulatory system" (3). If a person does develop congestive heart failure, digoxin
and diuretic therapy is warranted (2).
Another potential complication of refeeding syndrome is hypercapnia.
Hypercapnia is "an increased amount of carbon dioxide in the blood" (8). Refeeding
with excessive calories stimulates an increase in BMR and hepatic lipogenesis (4). The
respiratory quotient for lipogenesis is greater than one (4). Respiratory quotient (RQ) is
the ratio of carbon dioxide to oxygen (9). A normal RQ representing the mixed
utilization of carbohydrate, protein, and fat is near 0 83; an RQ greater than 1.0 indicates
excessive fat synthesis, overfeeding, and an excessive production of carbon dioxide
(9,10).
Hyperglycemia is another potential complication of refeeding syndrome.
Administering glucose to starved patients is good because it decreases the use of amino
acids for energy which promotes positive nitrogen balance (note glucose is not sufficient
in itself to produce positive nitrogen balance) (1,2). However, hyperglycemia may result
due to the rapid infusion of intravenous glucose or high carbohydrate enteral formulas
(4). Rapid infusion means glucose administration exceeds 4-7 mg/kg/minute (1).
Hyperglycemia occurs because insulin secretion is inadequate to handle rapid glucose
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infusion. If hyperglycemia is left uncontrolled, it can lead to dehydration,
cerebrovascular thrombosis, hyperglycemic hyperosmolar nonketotic coma (HHNK), or
death (1,2,4, 7). HHNK is rare but it has a mortality rate of 40-50% (4).
Another complication of refeeding syndrome is rebound hypoglycemia. This
occurs with an abrupt discontinuation of nutrition support, which creates a relative excess
of insulin (4, 7). Whenever it is necessary to discontinue parenteral nutrition, the infusion
rate should be tapered over several hours to prevent rebound hypoglycemia (7).
Hypophosphatemia is another complication ofrefeeding syndrome. In fact, it is
the most frequently cited electrolyte abnormality of refeeding syndrome (1). A normal
phosphorus level is 2.2 or 3.0-4.5 mg/dl (1,11). Depletion of body phosphorous stores
can occur without the serum level changing due to adjustments in renal excretion rate
(1,2). This type of depletion occurs in starvation. Brooks' and Melnik's (1) four
mechanisms of hypophosphatemia include: 1) decreased dietary intake; 2) ineffective
gastrointestinal absorption due to antacids, Crohn's disease, or steatorrhea; 3) increased
renal and nonrenal losses (not applicable in refeeding syndrome); and 4) transcellular
shifts (the primary mechanism of severe hypophosphatemia in hospitalized patients). As
discussed previously, phosphorus moves rapidly into intracellular fluid from extracellular
fluid in anabolism due to increased ATP requirements (1,4). Some possible
consequences of hypophosphatemia include cardiac, hematologic, hepatic,
neuromuscular, respiratory, and skeletal abnormalities (2).
Cardiac abnormalities associated with hypophosphatemia include altered
myocardial function, arrhythmia, congestive heart failure, and sudden death (2). One
proposed mechanism for cardiac abnormalities in hypophosphatemia is that reduced
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phosphate levels lead to decreased ATP levels, and this leads to depressed myocardial
contractility (2). Another theory is hypophosphatemia causes direct myocardial damage
(2).
Some hematologic consequences of hypophosphatemia include altered red blood
cell (RBC) morphology, tissue hypoxia, hemolytic anemia, white blood cell (WBC)
dysfunction, thrombocytopenia, depressed platelet function, and hemorrhage (2, 7). Red
blood cell abnormalities occur in hypophosphatemia because red blood cells have no
mitochondria; consequently, their levels mirror serum levels (1). Actin and myosin
analogs in red blood cells require phosphate in the form of ATP to maintain normal
characteristics (1). Consequently, red blood cells can't maintain their normal
characteristics in hypophosphatemia.

Red blood cell abnormalities can cause tissue

hypoxia. This is because red blood cells carry oxygen in the body, and if they are
deformed, capillary transit is reduced (2, 7). In addition, severe degrees of
hypophosphatemia have been associated with reductions in red blood cell 2,3diphosphoglycerate (2,3-DPG), which plays an important role in promoting the release of
oxygen from hemoglobin (2,7). Consequently, the RBC's affinity for oxygen is
increased and the delivery of oxygen to tissues is decreased which results in tissue
hypoxia (2). One theory for WBC dysfunction in hypophosphatemia is that a reduced
WBC ATP content negatively effects the "subcellular microtubular contraction of the
cells which interferes with such functions as pseudopod and vacuole formation involved
in chemotaxis and phagocytosis" (2).
Neuromuscular complications of hypophosphatemia are acute areflexic paralysis,
confusion, coma, cranial nerve palsies, diffuse sensory loss, Guillain-barre-like
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syndrome, lethargy, paresthesias, rhabdomyolysis, seizures, and weakness (2). The
mechanism of neurological disorders in hypophosphatemia is unknown (2). One
proposed mechanism is tissue hypoxia caused by hypophosphatemia alters tissue
function, which results in neuromuscular disorders (2).
The respiratory consequence of acute ventilatory failure is another consequence of
hypophosphatemia (2). A proposed mechanism for this is that the decrease in ATP,
which accompanies hypophosphatemia, causes a reduction in respiratory muscle
contraction (2). Liver dysfunction and osteomalacia are other consequences of
hypophosphatemia (2).
Another potential complication of refeeding syndrome is hypokalemia.
Hypokalemia is a "depletion of potassium in the circulating blood" (8). Potassium is an
intracellular cation (1). It is an "anabolic electrolyte" and 3mEq are required to build
lean tissue ( 1). In anabolism or refeeding extra potassium is required because "insulininduced glucose uptake by muscle facilitates an intracellular flux" of potassium (4).
Without extra potassium the serum or extracellular level may fall very low (1,4).
Possible consequences of this are cardiac arrhythmias, constipation, glucose intolerance,
muscle weakness, respiratory depression, lethargy, confusion, decreased urinary
concentrating ability, and coma (2,4). To prevent hypokalemia up to 160mEq of
potassium may be required during the first several days of refeeding (4, 7).
Hypomagnesemia is another potential complication of refeeding. Magnesium is
another "anabolic electrolyte" and 0. 5 mEq of it is required to build lean tissue (1). It is
a component of bone and it is found in intracellular fluid (7). In refeeding and anabolism
extra magnesium is necessary because starved cells may take up excessive magnesium
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and leave the extracellular fluid or serum lacking in it (1,2,4, 7). This lack of serum
magnesium or hypomagnesemia may have serious consequences. Some of these include
cardiac arrhythmias, anorexia, abdominal pain, nausea, vomiting, diarrhea, constipation,
irritability, depression, muscle tremors, personality changes, vertigo, tetany,
hyperreflexia, seizures, or painful paresthesias (2,4).
Another potential complication of refeeding syndrome is hypocalcemia. It may
be the consequence ofhypomagnesemia, hyperphosphatemia, hypoparathyroidism, or
hypoalbuminemia (7). If hypocalcemia is being caused by one of the above factors then
treatment should focus on correcting the underlying abnormality (4, 7). Low ionized
calcium levels may result in tetany and convulsions (4).
Methods of Prevention

Refeeding the malnourished patient disrupts the adaptive state of starvation (4).
For this reason, refeeding must proceed slowly and with close metabolic monitoring (4).
A good rule of thumb in refeeding is "to start low and go slow" (1). Solomon and Kirby
(2) gave some good recommendations to on how avoid refeeding syndrome. First, it is
important to be aware of the syndrome. Second, recognize the patient at risk. Third, test
for electrolyte abnormalities before beginning oral, enteral, or parenteral nutrition
support. Fourth, carefully monitor circulatory volume, pulse rate, and intake and output.
Fifth, increase caloric delivery slowly. Sixth, administer vitamins routinely. Seventh,
carefully monitor phosphorus, potassium, magnesium, glucose, and urinary electrolytes
over the first week. Last, "a little nutrition support is good, too much is lethal."
More specifically, refeeding should begin at less than 50% of a patient's
calculated nonprotein calories (1). Then caloric goals should be reached over at least

three to four days and be advanced as tolerated ( 1). Protein may be started at 1.5
g/kg/day based on actual or ideal body weight (1,2). Fluid intake should be limited to
800 ml/day during the first week to prevent fluid overload and cardiopulmonary
complications (1 ). Serum electrolytes need to be monitored and supplemented before and
during refeeding (1,2).
Conclusions
Refeeding syndrome is a syndrome of electrolyte abnormalities which occurs in
patients who are fed orally, enterally, or parenterally (1). Patients at high risk of getting
refeeding syndrome include people with chronic malnutrition-underfeeding, classic
kwashiorkor, classic marasmus, anorexia nervosa, chronic alcoholism, morbid obesity
with massive weight loss, patients unfed in 7-10 days with evidence of stress and
depletion, patients with prolonged fasting, and patients with prolonged intravenous
hydration (1,2). Characteristics or complications of refeeding syndrome include
congestive heart failure, hypercapnia, hyperglycemia, rebound hypoglycemia,
hypophosphatemia, hypokalemia, hypomagnesemia, and hypocalcemia. Prevention is the
key in refeeding syndrome and it can be done by remembering "to start low and go
slow"(l). Another important part of prevention is monitoring and supplementing
electrolytes if necessary before and during refeeding.
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